Health Bellwether J&J Slumps As Middle East Conflict Hampers Medtech Sales
Still, he rates J&J stock an outperform with a 290 price target. IBD Newsletters. Get exclusive IBD analysis and actionable news daily. SIGN UP NOW!
... continue reading.Health Bellwether J&J Slumps As Middle East Conflict Hampers Medtech Sales Read More »